 CRANFORD, N.J. , May 18, 2022 PRNewswire -- Citius Pharmaceuticals, Inc. Citius or the Company Nasdaq: CTXR, a late-stage biopharmaceutical company developing and commercializing first-in-class critical care products, today announced that it will present at the H.C. 